S4 E25, Dr. Nerissa Kreher - Chief Medical Officer of Alltrna

Reimagining Rare Disease Drug Development with Nerissa KreherIn this episode of She Leads Biotech, I’m joined by Nerissa Kreher, Chief Medical Officer of Alltrna, for a conversation about rare disease innovation, precision medicine, and the future of drug development.With more than 20 years of experience in rare diseases, Nerissa shares her journey from pediatric endocrinologist to biotech executive and explains how Alltrna is taking a novel approach to treating genetic diseases through mutation-defined therapies.A fascinating discussion about science, innovation, leadership, and hope for families living with rare diseases.Chapters00:00 Introduction02:00 From Medicine to Biotech05:00 Falling in Love with Rare Disease Research08:00 Understanding Rare Disease Communities12:00 The Challenge of Clinical Trials in Rare Diseases16:00 Mutation-Defined Therapies Explained21:00 How Alltrna Is Rethinking Drug Development26:00 Regulatory & Clinical Development Challenges31:00 Public vs Private Company Leadership35:00 What Makes a Great Biotech Executive39:00 Leadership, Mentorship & Authenticity43:00 The Role of Patients in Drug Development47:00 The Future of Rare Disease Innovation51:00 Bringing Hope to Patients & Families#SheLeadsBiotech #RareDisease #PrecisionMedicine #GeneTherapy #BiotechLeadership #WomenInBiotech #CNAUSAExecutiveSearch